Fujifilm Biotechnologies is unveiling a precision purification tool, ShunzymeX, that simplifies downstream processing for ...

Codexis has agreed to manufacture 50 grams of siRNA using its proprietary ECO Synthesis manufacturing platform to support ...

Rovadicitinib is approved in China for myelofibrosis and is in late-stage development for chronic graft-versus-host disease.

Moderna has entered into a settlement agreement resolving all worldwide Arbutus Biopharma Corporation/Genevant Sciences GmbH ...

Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting KIT-driven cancers.

Purchases a GEA Pharma-SD type PSD-4 solvent-capable spray dryer designed to produce commercial batches up to 500 kg.

Antheia has expanded the scope of its second project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium, securing an additional $9 million.

Duvakitug is currently in phase 3 trials for ulcerative colitis and Crohn’s disease.

Will house process development and analytical services for advanced peptide API production from development through commercialization.

CellCarta, a global CRO laboratory to the biopharmaceutical industry, has appointed Ehab A. El-Gabry, MD, as Chief Medical ...

ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...